LENSAR, Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
LNSR$5.46+0.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
BALANCE SHEETS
| As of December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $12,974 | $16,263 |
| Short-term investments | 5,004 | 6,192 |
| Accounts receivable, net of allowance of $62 and $105, respectively | 6,377 | 6,085 |
| Notes receivable, net of allowance of $6 and $8, respectively | 295 | 395 |
| Inventories | 21,520 | 11,428 |
| Prepaid and other current assets | 601 | 1,616 |
| Total current assets | 46,771 | 41,979 |
| Property and equipment, net | 505 | 664 |
| Equipment under lease, net | 15,485 | 13,767 |
| Notes and other receivables, long-term, net of allowance of $15 and $23, respectively | 731 | 1,160 |
| Intangible assets, net | 5,191 | 6,112 |
| Other assets | 2,747 | 2,615 |
| Total assets | $71,430 | $66,297 |
| Liabilities, redeemable convertible preferred stock, and stockholders’ (deficit) equity | ||
| Current liabilities: | ||
| Accounts payable | $18,982 | $5,995 |
| Accrued liabilities | 7,771 | 6,807 |
| Deferred revenue | 3,074 | 1,677 |
| Operating lease liabilities | 747 | 524 |
| Acquisition-related deposit | 10,000 | — |
| Total current liabilities | 40,574 | 15,003 |
| Long-term operating lease liabilities | 1,988 | 2,090 |
| Warrant liabilities | 40,194 | 29,856 |
| Other long-term liabilities | 909 | 702 |
| Total liabilities | 83,665 | 47,651 |
| Commitments and contingencies (Note 11) | ||
| Series A Redeemable Convertible Preferred Stock, par value $0.01 per share, 20 shares authorized at December 31, 2025 and 2024; 20 shares issued and outstanding at December 31, 2025 and 2024; aggregate liquidation preference of $20,000 at December 31, 2025 and 2024 | 13,784 | 13,784 |
| Stockholders’ (deficit) equity: | ||
| Preferred stock, par value $0.01 per share, 9,980 shares authorized at December 31, 2025 and 2024; no shares issued and outstanding at December 31, 2025 and 2024 | — | — |
| Common stock, par value $0.01 per share, 150,000 shares authorized at December 31, 2025 and 2024; 11,993 and 11,654 shares issued and outstanding at December 31, 2025 and 2024, respectively | 120 | 116 |
| Additional paid-in capital | 151,432 | 148,035 |
| Accumulated other comprehensive income | 4 | 6 |
| Accumulated deficit | (177,575) | (143,295) |
| Total stockholders’ (deficit) equity | (26,019) | 4,862 |
| Total liabilities, redeemable convertible preferred stock, and stockholders’ (deficit) equity | $71,430 | $66,297 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.